Roberto Cabrera
Grupo de investigación
- Investigación aplicada en infecciones respiratorias y enfermo crítico Assistant researcher (R2C)
Publicaciones destacadas
-
A long-lasting porcine model of ARDS caused by pneumonia and ventilator-induced lung injury
Autores:Referencia: Critical Care 2023. -
The value of biofilm testing to guide antimicrobial stewardship in chronic respiratory diseases
Autores:Referencia: Frontiers In Cellular And Infection Microbiology 2023. -
Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia
Autores:Referencia: Critical Care 2023. -
Resistance mechanisms and molecular epidemiology of Pseudomonas aeruginosa strains from patients with bronchiectasis
Autores:Referencia: Journal Of Antimicrobial Chemotherapy 2022. -
Short-Term Effects of Appropriate Empirical Antimicrobial Treatment with Ceftolozane/Tazobactam in a Swine Model of Nosocomial Pneumonia
Autores:Referencia: Antimicrobial Agents And Chemotherapy 2021. -
Molecular characterization of methicillin-resistant Staphylococcus aureus clinical strains from the endotracheal tubes of patients with nosocomial pneumonia
Autores:Referencia: Antimicrobial Resistance And Infection Control 2020. -
Class 1 integrons in Salmonella strains causing traveler''s diarrhea
Autores:Referencia: Antimicrobial Agents And Chemotherapy 2006.
Proyectos destacados
-
Diagnostic value of the Biofire® Filmarray panel compared to gram stain and conventional sputum in patients with exacerbations of bronchiectasis.
Duración: 02/02/2020 - 31/12/2022 -
The effects of aerosolized amikacin in pigs with severe Pseudomonas aeruginosa pneumonia
Investigador/a principal: Antoni TorresFinanciador: HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA (Participante)Duración: 01/01/2017 - 01/01/2018